Documents
Application Sponsors
ANDA 203593 | WATSON LABS INC | |
Marketing Status
Application Products
001 | TABLET;ORAL | 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG | 0 | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2016-10-11 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
WATSON LABS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 203593
[companyName] => WATSON LABS INC
[docInserts] => ["",""]
[products] => [{"drugName":"DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM","activeIngredients":"DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM","strength":"3MG,N\/A;0.02MG,N\/A;0.451MG,0.451MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/11\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/203593Orig1s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"10\/11\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/203593Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/203593Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2016-10-11
)
)